![Gavin Upiter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Justin Hanka | M | 50 |
MindBio Therapeutics Pty Ltd.
![]() MindBio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology MindBio Therapeutics Pty Ltd. is a multi-award-winning leader in microdosing psychedelic medicines. The company is based in Melbourne, Australia, and has subsidiaries in Australia. MindBio Therapeutics is focused on creating treatments for mental health conditions, and its clinical trials focusing on microdosing psychedelic medicines provide hope for sufferers of mental health conditions. The Australian company has conducted a randomized, double-blind, placebo-controlled trial to study the effects of repeated microdoses of lysergic acid diethylamide (LSD) on creativity and brain activity in healthy adult males. MindBio Therapeutics was founded by Justin Adam Hanka, and the CEO is Colin Keating. | 4 years |
John Dinan | M | 64 | 1 years | |
Lip Keat Tan | M | 50 |
Amneal Pharmaceuticals Pty Ltd.
![]() Amneal Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Amneal Pharmaceuticals Pty Ltd. develops, manufactures, markets and distributes generic drugs. It offers buprenorphine and naloxone tablets, ear drops, scalp and body oils, liquid syrups, folic acid tablets, oral solids, and nasal sprays. The company was founded in 2013 and is headquartered in Melbourne, Australia. | 10 years |
Zena Burgess | M | 66 |
MindBio Therapeutics Pty Ltd.
![]() MindBio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology MindBio Therapeutics Pty Ltd. is a multi-award-winning leader in microdosing psychedelic medicines. The company is based in Melbourne, Australia, and has subsidiaries in Australia. MindBio Therapeutics is focused on creating treatments for mental health conditions, and its clinical trials focusing on microdosing psychedelic medicines provide hope for sufferers of mental health conditions. The Australian company has conducted a randomized, double-blind, placebo-controlled trial to study the effects of repeated microdoses of lysergic acid diethylamide (LSD) on creativity and brain activity in healthy adult males. MindBio Therapeutics was founded by Justin Adam Hanka, and the CEO is Colin Keating. | 1 years |
Colin Keating | M | - |
MindBio Therapeutics Pty Ltd.
![]() MindBio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology MindBio Therapeutics Pty Ltd. is a multi-award-winning leader in microdosing psychedelic medicines. The company is based in Melbourne, Australia, and has subsidiaries in Australia. MindBio Therapeutics is focused on creating treatments for mental health conditions, and its clinical trials focusing on microdosing psychedelic medicines provide hope for sufferers of mental health conditions. The Australian company has conducted a randomized, double-blind, placebo-controlled trial to study the effects of repeated microdoses of lysergic acid diethylamide (LSD) on creativity and brain activity in healthy adult males. MindBio Therapeutics was founded by Justin Adam Hanka, and the CEO is Colin Keating. | - |
Lahiru Russell | M | - | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 4 | 66.67% |
Australia | 4 | 66.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gavin Upiter
- Personal Network